Guest guest Posted July 5, 2008 Report Posted July 5, 2008 Acute Hepatic Dysfunction With Abdominal Pain and Ascites From Medscape General Medicine Differential Diagnosis What is the cause of this patient's severe, painful ascites? Painful, severe ascites can be due to peritoneal diseases such as malignancy or tuberculosis. In such cases, however, the peritoneal fluid usually shows cells suggesting inflammation or malignancy. This patient's ascitic fluid had very few cells. Also, in ascites due to malignancy or infection, the SAAG is usually < 1.1. This helpful number, calculated by subtracting the albumin concentration in the ascitic fluid from the albumin concentration in the serum, reliably tells the clinician whether portal hypertension is present (SAAG > 1.1) or absent (SAAG < 1.1). Ascites due to the following diseases is usually associated with SAAG < 1.1: peritoneal malignancy, peritoneal tuberculosis, pancreatic ascites, renal disease, and severe hypoalbuminemia (malnutrition, protein-losing enteropathy, or nephrotic syndrome). The SAAG of 1.4 in this patient suggests that the painful ascites is due to portal hypertension. Pressure in the portal venous system rises when the flow of blood from the portal vein, through the hepatic sinusoids and out the hepatic veins, is impeded. Subacute severe portal hypertension with ascites can be seen with prehepatic (ie, portal vein thrombosis or occlusion), hepatic (ie, fulminant hepatic failure, infiltrative malignancy or infection, sinusoidal obstruction syndrome), or posthepatic (ie, hepatic vein obstruction -- Budd-Chiari syndrome) causes. This is why hepatic imaging studies are the most crucial additional tests to properly diagnose this case. A high-quality computed tomography (CT) scan with intravenous contrast (dangerous in this patient with renal insufficiency) or MRI scan with intravenous gadolinium (safer study in a patient such as ours with a creatinine of 1.7 mg/day) should be able to differentiate the following possible causes of acute portal hypertension: portal vein obstruction, hepatic mass lesion(s) with or without portal vein obstruction, or hepatic venous outflow obstruction. Before the imaging study is performed, we also know another remarkable feature of this man's liver disease: The hepatic injury is not nearly as bad as the ascites. Severity of acute hepatic injury usually correlates directly with the height of the bilirubin, aminotransferase, alkaline phosphatase, and INR values; it correlates inversely with the albumin concentration. Therefore, in cases of fulminant hepatitis due to drugs, toxins, autoimmune hepatitis, or viral hepatitis, these laboratory tests are typically very abnormal before the onset of severe painful ascites. To reiterate, most causes of acute severe hepatitis (drug, toxin, or autoimmune) would be expected to produce aminotransferase levels in the thousands and bilirubin concentrations in the double-digit range before producing severe painful ascites due to portal hypertension. With these 2 prominent clinical features in mind ("bad" portal hypertension and "not so bad" hepatic injury), we can now look at the suggested diagnostic possibilities. The reason acute autoimmune hepatitis was included in the list is because the patient has 2 suggestive clinical features: a prior history of autoimmune disease and a positive ANA test. Autoimmune hepatitis is an important and treatable cause of fatal acute liver disease. However, the sequence of events described in this patient (ascites first in the setting of moderate liver injury) doesn't quite fit. Still, liver biopsy will be a high priority in this patient. The same can be said for acute drug-induced hepatitis.This is one of the most common causes of lethal acute hepatitis, and the drugs and supplements that this patient is taking put him at risk. Toxin- or drug-induced liver disease should show severe biochemical abnormalities before the portal pressure rises enough to produce painful ascites. Therefore, the 2 best choices on the list of diagnostic possibilities are those disorders that produce primarily hepatic venous obstruction. One is hepatic sinusoidal obstruction syndrome, formerly called hepatic veno-occlusive disease.[3] This disease is most commonly seen in the setting of high-dose chemotherapy and total-body irradiation in recipients of hematopoietic stem cell transplantation.[4] The drugs, radiation, and opportunistic infections associated with this treatment produce sinusoidal endothelial damage. Hepatic venous blood flow is severely compromised and portal hypertension develops. Hepatic sinusoidal obstruction syndrome was originally described in association with ingestion of pyrrolizidine alkaloids (monocrotaline) in Jamaican herbal tea.[2] It has subsequently been seen in association with herbal remedies in India, Egypt, Israel, and South Africa. The subacute onset of portal hypertensive ascites in this patient combined with the impressive history of herbal remedies makes this entity important to consider. The diagnosis could be suggested by imaging studies showing diffuse hepatic injury and decreased hepatic venous blood flow and low or reversed blood flow in the portal vein.[3] Biopsy and measurement of the hepatic portal-hepatic venous pressure gradient could provide definitive diagnosis. However, most cases of hepatic sinusoidal obstruction syndrome are associated with impressive jaundice, in proportion to the sinusoidal block.[3] The combination of high portal pressure and normal bilirubin level make this diagnosis less likely. The best answer among those diagnostic possibilities listed would be acute obstruction of the hepatic vein (Budd-Chiari syndrome).The presentation of Budd-Chiari syndrome can be fulminant, acute, or chronic.Fulminant Budd-Chiari syndrome presents with severe pain, hepatomegaly, jaundice, ascites, and rapid deterioration of hepatic function. These patients frequently develop encephalopathy. Mortality is high, and it is most commonly seen in association with pregnancy. Chronic Budd-Chiari syndrome presents with decompensated cirrhosis. The liver is usually large and firm. Ascites may or may not be present. Patients typically have evidence of liver disease going back months to years. Acute nonfulminant Budd-Chiari syndrome is characterized by ascites, tender hepatomegaly, and abdominal pain. Encephalopathy is not a characteristic of this presentation. The acute nonfulminant presentation evolves over the course of several weeks, and some patients have a remitting course. Laboratory abnormalities vary widely with this presentation, but most commonly hepatocellular damage is reflected more often than a cholestatic picture. About 25% to 30% of cases of Budd-Chiari syndrome present acutely. Best Regards Mohammad Bashaar From: Vijay <drvijaythawani@...>Subject: Gulran/Charmak/Camel Belly Disease in Afghanistannetrum Date: Sunday, July 6, 2008, 5:17 AM Hi NetRUMians,The posts on the discussion topic seem to have slowed down.Come on, make the best of the Sunday and enliven the discussion.Expecting your active participation,Vijay Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.